University of California San Diego received $1.7 billion in grants over the previous year, funding that fueled critical research in human health, national defense, advanced technology, social sciences, and much more.
After diagnosis with liver disease, patient Rosa Tellez-Moore opts to participate in clinical trials, which change the trajectory of her treatment.
Researchers have developed a novel method to stimulate and mature human brain organoids using graphene, a one-atom-thick sheet of carbon.
The California Institute for Regenerative Medicine (CIRM) Scholars program seeks to develop skilled leaders in the field of regenerative medicine who create safe, cutting-edge stem cell treatments for diseases without cure like cancer, diabetes, heart disease and HIV.
University of California San Diego recently welcomed the U.S. Food and Drug Administration (FDA) Commissioner Martin Makary, M.D., M.P.H., to its Moores Cancer Center for a pivotal industry town hall.
Recognized among the best universities in the nation and the world in the 2025 Academic Ranking of World Universities, UC San Diego continues to deliver discoveries with global impact.
SciTech Daily, January 8
La Jolla Light, December 31
La Jolla Light, December 15
Keep up with all the latest from UC San Diego. Subscribe to the newsletter today.
